drugset / Trial / NCT01076582

Comparative Trial in Hormone Withdrawal Associated Symptoms

NCT01076582

Phase 3 Completed 592 enrolled Bayer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This clinical research study will examine whether an oral contraceptive pill taken with a monthly hormone-free interval of 4 days reduces hormone withdrawal associated symptoms compared to an oral contraceptive pill taken with a monthly hormone-free interval of 7 days after 4 cycles of treatment.

Timeline

Start
2010-04
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desogestrel Small molecule 0.15 mg Oral
Subject drospirenone Unknown 3 mg Oral
Comparator ethinyl estradiol Small molecule 0.02 mg Oral

Indications

No indication recorded.